Viewing StudyNCT02099565



Ignite Creation Date: 2024-05-06 @ 2:39 AM
Last Modification Date: 2024-10-26 @ 11:21 AM
Study NCT ID: NCT02099565
Status: COMPLETED
Last Update Posted: 2016-02-25
First Post: 2014-03-25

Brief Title: Observational Prospective Study OPTIMA II - Follow-up
Sponsor: AstraZeneca
Organization: AstraZeneca

Conditions & Keywords Data

Conditions:
Name
Major Adverse Cardiovascular and Cerebrovascular Events MACCE
Keywords:
Name View
Percutaneous Coronary Intervention PCI View
Major Adverse Cardiovascular and Cerebrovascular Events MACCE View
Statins View
LDL-cholesterol View
Inflammatory markers View